-
Symbol
-
TPST on Nasdaq
-
Investment type
-
Equity - Shares of Stock
-
Class
-
Common Stock, par value $0.001 per share
-
Latest Disclosed Ownership
-
2.12M shares
-
Security Ownership
-
4.8%
Versant Vantage II, L.P. ownership in Tempest Therapeutics, Inc. Common Stock, par value $0.001 per share (TPST)
2025-02-11 - Versant Vantage II, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.12M shares of Tempest Therapeutics, Inc. Common Stock, par value $0.001 per share (TPST).
This represents 4.8% percent ownership of the company.